Products for Research Use Only
RegisterLogin

Ecallantide (TFA)

CAT: 0804-HY-108814A-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-108814A-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Ecallantide (DX-88) TFA is a specific recombinant plasma kallikrein inhibitor. Ecallantide inhibits the production of bradykinin. Ecallantide may be used to prevent acute attacks of angioedema[1].
CAS Number
9007-83-4
Product Name Alternative
DX-88 (TFA)
UNSPSC
12352209
Target
Kallikrein
Type
Peptides
Related Pathways
Immunology/Inflammation
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/ecallantide-tfa.html
Purity
98.94
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
CC[C@@H]([C@H]1C(N[C@@H](CC2=CC=C(O)C=C2)C(NCC(NCC(N[C@H]3CSSC[C@H]4C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C)C(N[C@@H](C)C(N[C@@H](CC5=CN=CN5)C(N6CCC[C@H]6C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC7=CNC8=CC=CC=C87)C(N[C@@H](CC9=CC=CC=C9)C(N[C@@H](CC%10=CC=CC=C%10)C(N[C@@H](CC(N)=O)C(N[C@@H]([C@H](CC)C)C(N[C@@H](CC%11=CC=CC=C%11)C(N[C@@H]([C@H](O)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(N)=O)C(N[C@H](C(N[C@@H](CCC(O)=O)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC%12=CC=CC=C%12)C(N1)=O)=O)=O)=O)CSSCC(NC([C@H](CCC(O)=O)NC([C@H](CCC(O)=O)NC([C@H](CC(C)C)NC([C@H](CO)NC([C@H](CCC(O)=O)NC([C@H](CC%13=CC=CC=C%13)NC([C@H](CCCNC(N)=N)NC([C@H](CC(N)=O)NC([C@H](CCC(N)=O)NC([C@H](CC(N)=O)NC(CNC([C@H](CCC(O)=O)NC3=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](CCSC)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)CC(O)=O)=O)CCCNC(N)=N)=O)[C@H](O)C)=O)CSSC[C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](N)CCC(O)=O)=O)C)=O)CCSC)=O)CC%14=CN=CN%14)=O)CO)=O)CC%15=CC=CC=C%15)=O)C(N[C@@H](C)C(N[C@@H](CC%16=CC=CC=C%16)C(N[C@@H](CCCCN)C(N[C@@H](C)C(N[C@@H](CC(O)=O)C(N[C@@H](CC(O)=O)C(NCC(N%17CCC[C@H]%17C(N4)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)C.OC(C(F)(F)F)=O.[x]
Molecular Formula
C305H442N88O91S8.xC2HF3O2
Molecular Weight
7053.81 (free base)
References & Citations
[1]Martello JL, et al. Ecallantide for treatment of acute attacks of hereditary angioedema. Am J Health Syst Pharm. 2012 Apr 15;69 (8) :651-7. [Content Brief]
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
Scientific Category
Peptides
Clinical Information
Phase 3
Citation 01
Pharmacol Res. 2024 Nov:209:107460.|Arch Toxicol. 2025 Jun 4.

Related Products

CatalogName
HY-108814Ecallantide
HY-P5380ATNO211 (TFA)
HY-P4668A-01Valylleucine (TFA)
HY-P11296A-01LLVK (TFA)
HY-P10927A-01BRP (TFA)
HY-P10333A-01LIH383 (TFA)
HY-P3970D-01KQFK (TFA)
HY-P3460A-01TDSRCVIGLYHPPLQVY (TFA)
HY-P1723ASpexin (TFA)
HY-P10471A-01MPSD (TFA)

Alternative Products

CatalogName
MBS5824162Ecallantide TFA
MBS5820237Ecallantide
A8967-1EZM0414 TFA
C8651-10Pentosidine TFA
A8958-100Box5 TFA
B5867-200SCH772984 TFA
B8792-5GsMTx4 TFA
330135Gardiquimod TFA
563453Cenupatide TFA
563651SSM3 TFA

Popular Products